New systemic AAV for lung endothelium

CLOVER-affiliated graduate student David Goertsen along with former Postdoctoral Fellow Nick Goeden and former CLOVER Director Nick Flytzanis developed and characterized a new systemic AAV for targeting lung endothelium, AAV9.452sub.LUNG1. Check it out in the latest issue of Molecular Therapy - Methods & Clinical Development. Congratulations!

AAV9.452sub.LUNG1 is available now at Addgene!

This work also highlights a custom image processing pipeline to quantify transgene expression across whole tissue images. Try it out here!